PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

UIN 16655

Prostate Cancer: Screening

Original

answeredUnited Kingdom· UK Parliament· EN

Introduced

27 November 2024

Last action

2 December 2024 · Answer

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

2 December 2024

Summary

To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that guidance to primary care clinicians on screening for prostate cancer includes reference to the potential impact of the BRCA2 gene variation on risk levels.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 27 November 2024

    Written question

    To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that guidance to primary care clinicians on screening for prostate cancer includes reference to the potential impact of the BRCA2 gene variation on risk levels.

    Source: Commons

  2. 2 December 2024

    Answer

    The Prostate Cancer Risk Management Programme provides guidance for general practitioners on how to counsel men who have no symptoms but wish to have a Prostate Specific Antigen (PSA) test for prostate cancer. It highlights the potential benefits and harm...

    Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.